Loading clinical trials...
Loading clinical trials...
Phase IV, Two-arm, Open-label, Single-centre Randomised Pilot Study to Assess the Feasibility of Immediate or Deferred Switching of HIV-infected Individuals Intolerant of Efavirenz, Ritonavir-boosted Lopinavir or Ritonavir-boosted Darunavir
Conditions
Interventions
darunavir
ritonavir
Locations
1
United Kingdom
Chelsea and Westminster Hospital
London, United Kingdom
Start Date
October 1, 2008
Primary Completion Date
July 1, 2010
Completion Date
July 1, 2010
Last Updated
November 1, 2010
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
St Stephens Aids Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions